<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05095961</url>
  </required_header>
  <id_info>
    <org_study_id>5210327</org_study_id>
    <nct_id>NCT05095961</nct_id>
  </id_info>
  <brief_title>Pre-operative Steroids in CRSsP</brief_title>
  <official_title>Effect of Pre-operative Oral Steroids on Blood Loss in Endoscopic Sinus Surgery for Chronic Rhinosinusitis Without Polyps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial to determine the effectiveness of a five-day course of&#xD;
      pre-operative oral steroids on decreasing intra-operative blood loss during endoscopic sinus&#xD;
      surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a randomized cohort study, and patients will be recruited before surgery.&#xD;
      Following randomization, patients will be given either a course of Prednisone (30 milligrams&#xD;
      per day for 5 days, to be started five days prior to surgery) or no additional pre-operative&#xD;
      prescriptions besides what is clinically determined by their treating physician. Patients&#xD;
      will be scheduled for surgery and undergo functional endoscopic sinus surgery with timing as&#xD;
      clinically indicated.&#xD;
&#xD;
      During endoscopic sinus surgery, surgical video will be recorded and stored on encrypted,&#xD;
      flash drives with unique, non PHI, indicators to identify drives. Subsequently, each video&#xD;
      will be graded by two, blinded surgeons for field visualization and thoroughness of&#xD;
      dissection. Intra-operative blood loss will also be recorded. Post-operative data through 30&#xD;
      days post-operatively will be collected including: post-operative complications, resolution&#xD;
      of symptoms, and nasal crusting during post-operative follow up. Following completion of data&#xD;
      collection, these data will be analyzed by a separate, blinded investigator.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patient's will be randomized to one of two groups: pre-operative oral steroids or no control</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Clinicians grading blood loss and surgical field disability on the recorded video footage will be blinded to patient identity and group status. Data analysis will be done by a blinded assessor.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-operative blood loss - 1</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Measured intra-operative blood loss (in milliliters) as assessed by standard measure (total of blood in the suction canister [less the irrigation used])</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intra-operative blood loss - 2</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Blinded assessors grading of blood loss (in milliliters) as assessed by standard measure (total of blood in the suction canister [less the irrigation used])</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical field visibility</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Blinded assessor's grading of surgical field visualization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient intolerance of steroids</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Patient report of intolerable adverse effects of pre-operative steroids</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Chronic Sinus Disease</condition>
  <condition>Chronic Sinusitis, Ethmoidal</condition>
  <condition>Chronic Sinusitis, Sphenoidal</condition>
  <condition>Chronic Sinusitis - Maxillary Bilateral</condition>
  <condition>Chronic Sinusitis - Frontoethmoidal</condition>
  <arm_group>
    <arm_group_label>Pre-operative oral steroids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be given a course of oral prednisone (30mg daily) for 5 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No pre-operative medication will be prescribed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prednisone</intervention_name>
    <description>5 day course of oral prednisone pre-operatively. 30mg per day.</description>
    <arm_group_label>Pre-operative oral steroids</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients between the ages of 18 and 99 years of age with a diagnosis of chronic&#xD;
             rhinosinusitis without polyps who are being scheduled for functional endoscopic sinus&#xD;
             surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18 years old, patients with a condition in which the use of systemic&#xD;
             corticosteroids is contraindicated (poorly controlled diabetes mellitus, poorly&#xD;
             controlled hypertension, active or untreated tuberculosis, active viral or fungal&#xD;
             infection, acute angle glaucoma, osteoporosis, or acute congestive heart failure)&#xD;
             patients allergic to corticosteroids, or, patients unwilling or unable to take the&#xD;
             prescribed course of pre-operative steroids.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadia Chan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nadia Chan, MD</last_name>
    <phone>909-558-8558</phone>
    <email>NAChan@llu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ethan Frank, MD</last_name>
    <phone>909-558-8558</phone>
    <email>efrank@llu.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Govindaraj S, Adappa ND, Kennedy DW. Endoscopic sinus surgery: evolution and technical innovations. J Laryngol Otol. 2010 Mar;124(3):242-50. doi: 10.1017/S0022215109991368. Epub 2009 Nov 23. Review.</citation>
    <PMID>19930748</PMID>
  </reference>
  <reference>
    <citation>Linder TE, Simmen D, Stool SE. Revolutionary inventions in the 20th century. The history of endoscopy. Arch Otolaryngol Head Neck Surg. 1997 Nov;123(11):1161-3.</citation>
    <PMID>9366694</PMID>
  </reference>
  <reference>
    <citation>Moffatt DC, McQuitty RA, Wright AE, Kamucheka TS, Haider AL, Chaaban MR. Evaluating the Role of Anesthesia on Intraoperative Blood Loss and Visibility during Endoscopic Sinus Surgery: A Meta-analysis. Am J Rhinol Allergy. 2021 Sep;35(5):674-684. doi: 10.1177/1945892421989155. Epub 2021 Jan 21.</citation>
    <PMID>33478255</PMID>
  </reference>
  <reference>
    <citation>Wawrzyniak K, Burduk PK, Cywinski JB, Kusza K, Kazmierczak W. Improved quality of surgical field during endoscopic sinus surgery after clonidine premedication--a pilot study. Int Forum Allergy Rhinol. 2014 Jul;4(7):542-7. doi: 10.1002/alr.21308. Epub 2014 Mar 3.</citation>
    <PMID>24591266</PMID>
  </reference>
  <reference>
    <citation>Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation. Ann Otol Rhinol Laryngol. 2006 Jul;115(7):490-4.</citation>
    <PMID>16900802</PMID>
  </reference>
  <reference>
    <citation>Günel C, Başak HS, Bleier BS. Oral steroids and intraoperative bleeding during endoscopic sinus surgery. B-ENT. 2015;11(2):123-8.</citation>
    <PMID>26563012</PMID>
  </reference>
  <reference>
    <citation>Hwang SH, Seo JH, Joo YH, Kang JM. Does the Preoperative Administration of Steroids Reduce Intraoperative Bleeding during Endoscopic Surgery of Nasal Polyps? Otolaryngol Head Neck Surg. 2016 Dec;155(6):949-955. Epub 2016 Aug 23. Review.</citation>
    <PMID>27554509</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 29, 2021</study_first_submitted>
  <study_first_submitted_qc>October 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>Nadia Chan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
    <mesh_term>Ethmoid Sinusitis</mesh_term>
    <mesh_term>Sphenoid Sinusitis</mesh_term>
    <mesh_term>Paranasal Sinus Diseases</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

